Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
02/2003
02/11/2003US6517513 Intraductal breast fluid aspiration device
02/11/2003US6517496 Airway-based cardiac output monitor and methods for using same
02/11/2003US6517237 Measuring energy consumption
02/11/2003US6516953 Device for separating components of a fluid sample
02/11/2003US6516654 Apparatus and method for analyzing particulate matter in gas and apparatus and method for carbon differentiating
02/11/2003US6516653 Gas sensor arrangement
02/11/2003CA2251986C Apparatus for measuring a gas value
02/11/2003CA2231409C Antibodies specific for native prpsc
02/11/2003CA2174529C Dna encoding a hypothalamic atypical neuropeptide y/peptide yy receptor (y5) and uses thereof
02/11/2003CA2170509C Dna encoding prostaglandin receptor ep2
02/11/2003CA2166081C Ovulation method
02/11/2003CA2154620C Method of detecting surface contamination by an analyte
02/11/2003CA2152667C Bone resorption assay
02/11/2003CA2142301C Monitoring method
02/11/2003CA2142263C Monitoring method
02/11/2003CA2141554C Morphogen-induced nerve regeneration and repair
02/11/2003CA2139645C Immunoassays for anti-hcv antibodies using antigens with conformational epitopes
02/11/2003CA2133843C Melanocyte stimulating hormone receptor and uses
02/11/2003CA2100890C Particle measurement apparatus
02/11/2003CA2078689C Chimeric antibodies with receptor binding ligands in place of their constant region
02/08/2003CA2397251A1 Methods for detecting and extracting gold
02/07/2003CA2397182A1 New supported membrane, its preparation and uses
02/07/2003CA2392969A1 Method for determining real-time downhole mud properties while drilling
02/06/2003WO2003010999A2 Waterless vessel heating system and method
02/06/2003WO2003010556A2 Real-time digital x-ray imaging apparatus
02/06/2003WO2003010544A2 Method for the diagnosis of kidney damage in the early stages
02/06/2003WO2003010543A1 Assays for detecting, identifying and/or quantifying contaminants with liposomes
02/06/2003WO2003010542A1 Cancer diagnostics
02/06/2003WO2003010541A1 Method of assay by immunoreaction and reagent for use in the immunoreaction assay
02/06/2003WO2003010540A1 Method of identifying nmda-related agent
02/06/2003WO2003010539A1 Method and means for detecting alcohol consumption
02/06/2003WO2003010537A1 Family based tests of association using pooled dna and snp markers
02/06/2003WO2003010536A2 Tnf-alpha mimics and lead optimisation
02/06/2003WO2003010535A1 Improved real time method for controlling applications of fertilizers and other yield improving agents to crops
02/06/2003WO2003010534A2 Method for quantitative monitoring of a gas injected into a reservoir in particular in a natural environment
02/06/2003WO2003010530A1 Analyzing instrument
02/06/2003WO2003010520A1 Apparatus for measuring fruit properties including a function forautomatically controlling the intensity of light from a light source
02/06/2003WO2003010508A2 Assay for identifying anti-viral agents specific for protein-coated double-stranded dna viruses
02/06/2003WO2003010507A2 System for intracellular process monitoring and in vivo drug screening
02/06/2003WO2003010506A2 Combined electronic-and photonic-based hybridation assay
02/06/2003WO2003010338A1 Detection method of nucleic acid hybridization
02/06/2003WO2003010337A1 Scoring system for the prediction of cancer recurrence
02/06/2003WO2003010336A2 Molecular markers for hepatocellular carcinoma
02/06/2003WO2003010333A2 Methods for gene disruption and uses thereof
02/06/2003WO2003010331A2 Immobilisation of proteins and electroactive compounds on a sensor surface by means of a hydrophobin coating
02/06/2003WO2003010330A2 Test system and method suitable for selecting test materials and formulations
02/06/2003WO2003010326A2 Parallel, antiparallel, homologous or complementary binding of nucleic acids
02/06/2003WO2003010315A1 Abca7 splicing variant
02/06/2003WO2003010310A1 Method of examining allergic disease
02/06/2003WO2003010292A2 Methods and apparatus for enrichment and culture of monocytic dendritic cell precursors
02/06/2003WO2003010290A2 Novel class ii cytokine receptors and uses thereof
02/06/2003WO2003010289A2 Nanochannel arrays and their preparation and use for high throughput macromolecular analysis
02/06/2003WO2003010285A2 Functional site profiles for proteins and methods of making and using the same
02/06/2003WO2003010278A2 Automated process for detecting pathogenic organisms in water
02/06/2003WO2003010199A2 Identification of specific tumour antigens by means of the selection of cdna libraries with sera and the use of said antigens in diagnostic imaging techniques
02/06/2003WO2003010198A1 Identification of specific tumour antigens by selection of cdna libraries with sera and use of said antigens in diagnostic techniques
02/06/2003WO2003010196A2 Variants and exons of the glyt1 transporter
02/06/2003WO2003010190A2 Peptide screen
02/06/2003WO2003009943A1 System for separating magnetically attractable particles
02/06/2003WO2003009865A1 Agonists and antagonists of energen for use in the treatment of metabolic disorders
02/06/2003WO2003009864A1 Agonists and antagonists of disomet for the treatment of metabolic disorders
02/06/2003WO2003009863A1 Agonists and antagonists of cofoxin for use in the treatment of metabolic disorders
02/06/2003WO2003009862A1 Agonists and antagonists of modumet for use in the treatment of metabolic disorders
02/06/2003WO2003009861A1 Agonists and antagonists of metabolix in the treatment of metabolic disorders
02/06/2003WO2003009815A2 Compositions and methods for modulating blood-brain barrier transport
02/06/2003WO2003009814A2 Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of prostate cancer
02/06/2003WO2003009776A2 Urine test device
02/06/2003WO2003009667A2 Animal consumable labeling and method thereof
02/06/2003WO2002097428A3 Method of detecting pneumonia in a respiring patient
02/06/2003WO2002095034A3 A retinoic acid metabolizing cytochrome p450
02/06/2003WO2002093177A3 Assays for identifying modulators of rhomboid polypeptides
02/06/2003WO2002088720A3 Biopolymer marker having a molecular weight of 1348 daltons
02/06/2003WO2002086450A3 Compositions and methods for the identification of protein interactions in vertebrate cells
02/06/2003WO2002085667A3 Three cube fret method (33-fret) for detecting fluorescence energy transfer
02/06/2003WO2002081730A3 Trac1: modulators of lymphocyte activation
02/06/2003WO2002072805A3 Thymidylate synthase
02/06/2003WO2002068467A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
02/06/2003WO2002063005A3 Lipid-associated molecules
02/06/2003WO2002061126A3 The preparation of polynucleotide arrays
02/06/2003WO2002061034A3 Compositions and methods for rapidly generating recombinant nucleic acid molecules
02/06/2003WO2002060950A3 Flt4(vegfr-3) as a target for tumor imaging and anti-tumor therapy
02/06/2003WO2002059613A3 Oomycete ftsz-mt as a target for antimicrobial-specific biocides
02/06/2003WO2002059599A3 System and method for in vitro analysis of therapeutic agents
02/06/2003WO2002056826A3 Method for producing purified hematinic iron-saccharidic complex and product produced
02/06/2003WO2002056016A3 Method for identifying a ligand for a biological substrate
02/06/2003WO2002045323A3 Data relationship model
02/06/2003WO2002042735A9 Human kcr1 regulation of herg potassium channel block
02/06/2003WO2002042497A3 Methods using fluorescens energy transfer probes for detecting cleavage of nucleic acids
02/06/2003WO2002039949A9 Platelet/leukocyte interaction assay and reagent therefor
02/06/2003WO2002037103A9 Laser scanning cytometry mediated analysis of therapeutic efficacy in tumors
02/06/2003WO2002034887A3 Maturation of dendritic cells
02/06/2003WO2002033377A3 Biological markers for evaluating therapeutic treatment of inflammatory and autoimmune disorders
02/06/2003WO2002030937A3 Labeled resiniferatoxin derivatives for use in vanilloid receptor binding assay
02/06/2003WO2002021996A3 Methods of diagnosis of colorectal cancer, compositions and methods of screening for colorectal cancer modulators
02/06/2003WO2002021139A3 Automated identification of peptides
02/06/2003WO2002020722A3 Methods and compositions for in vitro targeting
02/06/2003WO2002010217A9 Endothelial cell expression patterns
02/06/2003WO2002006833A9 Improved non-luminescent substrate
02/06/2003WO2002004668A3 Improved capture and detection of target nucleic acid in dipstick assays
02/06/2003WO2002004596A9 Diagnosing and treating cancer cells using mutant viruses
1 ... 2657 2658 2659 2660 2661 2662 2663 2664 2665 2666 2667 2668 2669 2670 2671 2672 2673 2674 2675 2676 2677 ... 3937